Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro

High Altitude Medicine and Biology

Volumn 11, Issue 3, 2010, Pages 217-222

  Jackson, Stewart J ^a   Varley, James ^a   Sellers, Claudia ^a   Josephs, Katherine ^a   Codrington, Lucy ^a   Duke, Georgina ^a   Njelekela, Marina A ^b   Drummond, Gordon ^a   Sutherland, Andrew I ^a   Thompson, A A Roger ^a   Baillie, J Kenneth ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

acetazolamide; acute mountain sickness; altitude sickness; AMS; epidemiology; predictors; rest day

Indexed keywords

ACETAZOLAMIDE;

ADULT; AGED; ALTITUDE; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ARTICLE; AWARENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LAKE LOUISE CONSENSUS SCORE; MAJOR CLINICAL STUDY; MALE; MOUNTAINEERING; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUESTIONNAIRE; REST;

ACUTE DISEASE; ADULT; AGED; ALTITUDE SICKNESS; COMORBIDITY; ENVIRONMENTAL EXPOSURE; FATIGUE; FEMALE; HEADACHE; HUMANS; KENYA; MALE; MIDDLE AGED; MOUNTAINEERING; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; TRAVEL; WALKING; YOUNG ADULT;

EID: 77957743854     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/ham.2010.1003     Document Type: Article

References (28)

1. Armitage, P. (1971). Methods in Medical Research. John Wiley, New York.
2. Basnyat B., Lemaster J. and Litch J. A. (1999). Everest or bust: a cross sectional, epidemiological study of acute mountain sickness at 4243 meters in the Himalayas. Aviation Space Environ. Med. 70:867-73.
3. Basnyat B. and Murdoch D. R. (2003). High-altitude illness. Lancet. 361:1967-74.
4. Basnyat B., Gertsch J. H., Johnson E. W., Castro-Marin F., Inoue Y. and Yeh C. (2003). Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial. High Alt Med Biol. 4:45-52.
5. Birmingham Medical Research Expeditionary Society Mountain Sickness Study Group (1981). Acetazolamide in control of acute mountain sickness. Lancet. 1:180-3.
6. Bloch K. E., Turk A. J., Maggiorini M., Hess T., Merz T., Bosch M. M., Barthelmes D., Hefti U., Pichler J., Senn O. and Schoch O. D. (2009) Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546m. High Altitude Medicine & Biology. 10:25-32.
7. British National Formulary. Antimalarials. BNF section 5.4.1 (2009) Joint Formulary Committee, BMJ Group and RPS Publishing, London, pp. 357-366.
8. Davies A. J., Kalson N. S., Stokes S., Earl M. D., Whitehead A. G., Frost H., Tyrell-Marsh I. and Naylor J. (2009) Determinants of summiting success and acute mountain sickness on Mt Kilimanjaro (5895 m). Wilderness Environ Med. 20:311-7.
9. Dumont L., Tramer M. R., Lysakowski C., Mardirosoff C. and Kayser B. (2003) Efficacy of low-dose acetazolamide for the prophylaxis of acute mountain sickness. High Alt Med Biol. 4:399.
10. Forwand, S. A., Landowne, M., Follansbee, J. N. and Hansen, J. E. (1968) Effect of acetazolamide on acute mountain sickness. NEJM. 279:839-45.
11. Gaillard S., Dellasanta P., Loutan L., and Kayser B. (2004). Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: a 12-year follow-up. High Alt. Med. Biol. 5:410-19.
12. Gallagher S. A. and Hackett P. H. (2004). High-altitude illness. Emerg. Med. Clin. North Am. 22:329-55.
13. Greenwood P. E. and Nikulin, M. S. (1996) A guide to chi-squared testing. Wiley, New York.
14. Hackett P. H. and Oelz O. (1992). The Lake Louise consensus on the definition and qualification of altitude illness. In: Hypoxia Mountain Medicine. J. Sutton, G. Coates, and C. Houston, ed. Queen City Printers, Burlington, VT; pp. 327-30.
15. Hackett P. H. and Roach R. C. (2001). High-altitude illness. NEJM. 345:107-14.
16. Healthline.com. Drug Interaction Checker at http://www.healthline.com/ druginteractions?addItem=acetazolamide&addItem=mefloquine Accessed 14 March 2010
17. Hillenbrand P., Pahari A. K., Soon Y., Subedi D., Bajracharya R., Gurung P., Lal B. K., Marahatta R., Pradhan S., Rai D., Sharma S and Birmingham Medical Research Expeditionary Society. (2006) Prevention of acute mountain sickness by acetazolamide in Nepali porters: a double-blind controlled trial. Wilderness Environ Med. 2:87-93.
18. International Mountaineering and Climbing Federation at http://www.theuiaa.org/index.php accessed 14 March 2010
19. Kalson N. S., Thompson J., Davies A. J., Stokes S., Earl M. D., Whitehead A., Tyrrell-Marsh I., Frost H. and Montgomery H. (2009). The effect of angiotensin-converting enzyme genotype on acute mountain sickness and summit success in trekkers attempting the summit of Mt. Kilimanjaro (5, 895 m). European Journal of Applied Physiology. 105:373-9.
20. Karinen H., Peltonen J. and Tikkanen H. (2008). Prevalence of acute mountain sickness among Finnish trekkers on Mount Kilimanjaro, Tanzania: an observational study. High Alt Med Biol. 9:301-6.
21. Kayser B., Hulsebosch R. and Bosch F. (2008). Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness. High Alt Med Biol. 9:15-23.
22. Larsen, E. B., Roach, R. C., Schoene, R. B. and Hornbein, T. F. (1982). Acute mountain sickness and acetazolamide. Clinical efficacy and effect on ventilation. JAMA. 248:3.
23. Pesce C., Leal C., Pinto H., González G., Maggiorini M., Schneider M., and Bärtsch P. (2005). Determinants of acute mountain sickness and success on Mount Aconcagua (6962 m). High Alt Med Biol. 6:158-66.
24. Roach RC, Bartsch P, Hackett PH, Oelz O. The Lake Louise AMS Scoring Consensus Committee. The Lake Louise acute mountain sickness scoring system. In: Sutton JR, Coates G, Huston CS, ed. Hypoxia and molecular medicine: proceedings of the 8th international hypoxia symposium, 9-13 Feb, 1993; Lake Louise, Alberta, Canada. Burlington, VT: Queen City Printers, 1993:272-4.
25. Schlim and Dietz (2000). http://www.ismmed.org/np-altitude-tutorial. htm#goldenrules. Accessed 30/12/09.
26. Singh I., Khanna P. K., Srivastava M. C., Lal M., Roy S. B., and Subramanyam C. S. (1969). Acute mountain sickness. NEJM. 280:175-84.
27. van Patot M. C., Leadbetter G. 3rd, Keyes L. E., Maakestad K. M., Olson S. and Hackett P. H. (2008). Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness. High Alt Med Biol. 9:289-93.
28. West J. B., Schoene R. B. and Milledge J. S. (2007). High Altitude Medicine and Physiology. Hodder Arnold Publication; 4 ed. p264.